Calibr, JDRF partner to research on promising type 1 diabetes therapeutic targets

The California Institute for Biomedical Research and JDRF announced a partnership today to apply Calibr’s drug discovery expertise to type 1 diabetes research projects in collaboration with academic investigators from JDRF’s network.

See the original article here:
Calibr, JDRF partner to research on promising type 1 diabetes therapeutic targets

Share and Enjoy:
  • Print
  • Digg
  • StumbleUpon
  • Facebook
  • Yahoo! Buzz
  • Twitter
  • Google Bookmarks
  • Add to favorites
  • email
  • LinkedIn
  • RSS
  • Tumblr
Share